Download Our DHN Survey Result 2024
Realize your Healthcare’s Digital Transformation journey with ScaleHealthTech Learn More

Medical Devices Industry in Turmoil as New Law Restrains 200 Producers

Written by : Aishwarya Sarthe

October 5, 2023

Category Img

The medical devices industry faces disruption as 200 producers halt operations due to regulatory barriers. Twitterati expressed apprehensions, urging swift resolution.

The medical devices industry is facing a crisis as more than 200 manufacturers have been compelled to halt the supply of their products due to the non-approval of their manufacturing licence applications under a recently implemented law before the cutoff date of October 1, 2023.

The Central Drugs Standard Control Organisation (CDSCO), the regulatory body, is grappling with a backlog of over 500 pending applications for manufacturing licences, primarily for high-risk Class D and moderately high-risk Class C medicines, estimated Rajiv Nath, forum coordinator for the Association of Indian Medical Device Industry (AiMeD).

AiMED Seeking Quick Resolution

On this, AiMED reiterated the urgent need for clarity, highlighting that sales and billing are legally prohibited without a manufacturing licence. The association has requested an extension and proposed issuing permits based on audits by notified bodies until formal approvals are granted.

The new regulations, effective from October 1, 2023, require medical devices classified as Class C and D to comply with the Drugs and Cosmetics (D&C) Act as per the 2017 Medical Devices Rules.

The development has triggered a wave of concern among industry stakeholders and advocates. AiMeD (@MiIAiMeD) took to Twitter, seeking urgent assistance tagging the Union Minister for Health and Family Welfare, Mansukh Mandaviya (@mansukhmandviya), calling for the need to ensure a smooth transition into regulations without causing hardship to manufacturers and consumers.


Nikhil Kurele, cofounder and CEO of Noccarc, a Pune-based medical device company, highlighted the necessity for clear and immediate responses from the authorities. He expressed concern about the adverse impact of regulatory ambiguities on the sector's growth and highlighted the challenges startups like Noccarc face.


The situation has attracted the attention of various individuals and media, reflecting the severity of the crisis within the medical devices industry.

The recent events underscores the pressing need for streamlined regulatory processes and transparent communication to alleviate manufacturers' concerns and ensure the uninterrupted supply of vital medical devices.

About Chime India

The College of Healthcare Information Management Executives (CHIME) is an executive organization dedicated to serving senior digital health leaders. CHIME includes more than 5,000 members in 56 countries and two US territories and partners with over 150 healthcare IT businesses and professional services firms. CHIME enables its members and business partners to collaborate, exchange ideas, develop professionally and advocate the effective use of information management to improve the health and care throughout the communities they serve. CHIME's members are chief information officers (CIOs), chief medical information officers (CMIOs), chief nursing information officers (CNIOs), chief innovation officers (CIOs), chief digital officers (CDOs), and other senior healthcare leaders. The CHIME India Chapter became the first international chapter outside North America in 2016 and is now a community of over 70+ members in India. For more information, please visit


Digital Health News ( DHN) is India’s first dedicated digital health news platform launched by Industry recognized HealthTech Leaders. DHN Is Industry’s Leading Source Of HealthTech Business, Insights, Trends And Policy News.

DHN Provides In-Depth Data Analysis And Covers Most Impactful News As They Happen Across Entire Ecosystem Including Emerging Technology Trends And Innovations, Digital Health Startups, Hospitals, Health Insurance, Govt. Agencies & Policies, Pharmaceuticals And Biotech.

Contact us:

© Digital Health News 2024